CXCL12 and posterior cortical atrophy: Moreover, CXCL12 was identified as one of 38 other cytokines whose levels differed between PCa patients and healthy controls, suggesting that CXCL12 may serve as a biomarker for the early diagnosis and prognosis of PCa [508].